FDA Inspection 585206 — Baxter Healthcare Corporation
The FDA completed an inspection of Baxter Healthcare Corporation on May 14, 2009 in Jayuya, PR. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 14, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Jayuya, PR (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)